🐜
|
Association of PDCD1 with susceptibility to systemic lupus erythematosus: evidence of population-specific effects.
11 auth.
I. Ferreirós-Vidal,
J. Gómez-Reino,
F. Barros,
Á. Carracedo,
P. Carreira,
F. Gonzáléz-Escribano,
...
Myriam Liz,
Javier Martín,
J. Ordi,
J. Vicario,
Antonio González
|
7 |
2004 |
7 🐜
|
🐜
|
Familial CD8 deficiency due to a mutation in the CD8α gene
10 auth.
O. de la Calle‐Martín,
Manuel Hernández,
J. Ordi,
N. Casamitjana,
J. Aróstegui,
I. Caragol,
...
M. Ferrando,
M. Labrador,
J. Rodríguez-Sánchez,
T. Español
|
6 |
2001 |
6 🐜
|
🐜
|
Lack of association between anticardiolipin antibodies and migraine in systemic lupus erythematosus
9 auth.
J. Montalbán,
R. Cervera,
J. Font,
J. Ordi,
J. Vianna,
H. Haga,
...
M. Tintoré,
M. Khamashta,
G. Hughes
|
6 |
1992 |
6 🐜
|
🐜
|
Mannose binding lectin and FcgammaRIIa (CD32) polymorphism in Spanish systemic lupus erythematosus patients.
10 auth.
J. Villarreal,
D. Crosdale,
W. Ollier,
A. Hajeer,
W. Thomson,
J. Ordi,
...
E. Balada,
M. Villardell,
L. Teh,
K. Poulton
|
6 |
2001 |
6 🐜
|
🐬
|
Antiphospholipid antibodies in cerebral ischemia.
J. Montalbán,
A. Codina,
J. Ordi,
M. Vilardell,
M. Khamashta,
G. Hughes
|
6 |
1991 |
6 🐬
|
🐬
|
Tumor necrosis factor receptor II (TNFRII) exon 6 polymorphism in systemic lupus erythematosus.
A. al-Ansari,
W. Ollier,
J. Villarreal,
J. Ordi,
L. Teh,
A. Hajeer
|
6 |
2000 |
6 🐬
|
🦁
|
Thalidomide induces amenorrhea in patients with lupus disease.
J. Ordi,
F. Cortés,
Nuria Martinez,
Montse Mauri,
I. D. Torres,
M. Vilardell
|
6 |
1998 |
6 🦁
|
🐜
|
The value of complement activation products in the assessment of systemic lupus erythematosus flares.
9 auth.
J. Porcel,
J. Ordi,
A. Castro-Salomó,
M. Vilardell,
M. Rodrigo,
T. Gené,
...
F. Warburton,
M. Kraus,
D. Vergani
|
5 |
1995 |
5 🐜
|
🐜
|
Association of a non-synonymous single-nucleotide polymorphism of DNASEI with SLE susceptibility.
8 auth.
A. Bodaño,
Antonio Gonzalez,
I. Ferreirós-Vidal,
E. Balada,
J. Ordi,
Patricia Carreira,
...
J. Gómez-Reino,
Carmen Conde
|
5 |
2006 |
5 🐜
|